Marquette Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Marquette Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-730	Closed	-$17.1K	–	233
2024 Q2	$17.1K	Hold	730	–	–	﹤0.01%	162
2024 Q1	$21K	Sell	730 -120	-14%	-$3.61K	﹤0.01%	157
2023 Q4	$27.9K	Hold	850	–	–	0.01%	152
2023 Q3	$23.7K	Hold	850	–	–	0.01%	161
2023 Q2	$29K	Hold	850	–	–	0.01%	162
2023 Q1	$25.6K	Buy	850 +730	+608%	+$22.6K	0.01%	161
2022 Q4	$3.39K	Buy	+120	New	+$3.81K	﹤0.01%	198
2021 Q2	–	Sell	-120	Closed	-$11K	–	236
2021 Q1	$11K	Sell	120 -59	-33%	-$5.85K	﹤0.01%	211
2020 Q4	$17K	Buy	+179	New	+$14.3K	﹤0.01%	205

Other funds holding ARKG

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $3.3B AUM 33.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Marquette Asset Management's ARKG Position: Q3 2024 in Review

Marquette Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 730 shares — an estimated $17.1K sold.

Marquette Asset Management first reported a position in ARKG in Q4 2020 and held it in 9 quarters. The position peaked at $29K in Q2 2023. 240 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

Marquette Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
Marquette Asset Management sold 730 ARK Genomic Revolution ETF shares in Q3 2024, an estimated $17.1K.
Marquette Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 9 quarters.
Marquette Asset Management's ARK Genomic Revolution ETF position peaked at $29K in Q2 2023.
240 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Marquette Asset Management's 13F filing for Q3 2024, filed 8 Oct 2024.